- Home
- APA vs MDGL Comparison
APA vs MDGL Comparison
Compare APA & MDGL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- APA
- MDGL
- Stock Information
- Founded
- APA 1954
- MDGL 2011
- Country
- APA United States
- MDGL United States
- Employees
- APA N/A
- MDGL N/A
- Industry
- APA Oil & Gas Production
- MDGL Biotechnology: Pharmaceutical Preparations
- Sector
- APA Energy
- MDGL Health Care
- Exchange
- APA Nasdaq
- MDGL Nasdaq
- Market Cap
- APA 8.4B
- MDGL 9.6B
- IPO Year
- APA N/A
- MDGL N/A
- Fundamental
- Price
- APA $22.39
- MDGL $423.00
- Analyst Decision
- APA Hold
- MDGL Strong Buy
- Analyst Count
- APA 17
- MDGL 12
- Target Price
- APA $23.06
- MDGL $521.09
- AVG Volume (30 Days)
- APA 7.0M
- MDGL 277.8K
- Earning Date
- APA 11-05-2025
- MDGL 11-04-2025
- Dividend Yield
- APA 4.40%
- MDGL N/A
- EPS Growth
- APA N/A
- MDGL N/A
- EPS
- APA 2.94
- MDGL N/A
- Revenue
- APA $9,804,000,000.00
- MDGL $515,547,000.00
- Revenue This Year
- APA N/A
- MDGL $394.38
- Revenue Next Year
- APA N/A
- MDGL $64.73
- P/E Ratio
- APA $7.66
- MDGL N/A
- Revenue Growth
- APA 11.98
- MDGL 3421.98
- 52 Week Low
- APA $13.58
- MDGL $213.71
- 52 Week High
- APA $25.83
- MDGL $463.63
- Technical
- Relative Strength Index (RSI)
- APA 44.45
- MDGL 46.87
- Support Level
- APA $22.23
- MDGL $393.61
- Resistance Level
- APA $23.26
- MDGL $434.48
- Average True Range (ATR)
- APA 0.82
- MDGL 16.23
- MACD
- APA -0.15
- MDGL -2.55
- Stochastic Oscillator
- APA 12.84
- MDGL 51.20
About APA APA Corporation
APA Corp is an independent exploration and production company. It develops, and produces crude oil, natural gas, and natural gas liquids. The Company's business has oil and gas operations in three geographic areas: the United States (U.S.), Egypt, and offshore the U.K. in the North Sea (North Sea). APA also has active development, exploration, and appraisal operations ongoing in Suriname, as well as exploration interests in Uruguay, Alaska, and other international locations.
About MDGL Madrigal Pharmaceuticals Inc.
Madrigal Pharmaceuticals Inc is a biopharmaceutical company focused on delivering novel therapeutics for metabolic dysfunction-associated steatohepatitis (MASH), a serious liver disease with high unmet medical need that can lead to cirrhosis, liver failure, and premature mortality. The company's medication, Rezdiffra (resmetirom), is a once-daily, oral, liver-directed thyroid hormone receptor agonist designed to target key underlying causes of MASH.